| Literature DB >> 19929612 |
Xavier Robin1, Natacha Turck, Alexandre Hainard, Frédérique Lisacek, Jean-Charles Sanchez, Markus Müller.
Abstract
A large number of biomarkers have been discovered over the past few years using proteomics techniques. Unfortunately, most of them are neither specific nor sensitive enough to be translated into in vitro diagnostics and routine clinical practice. From this observation, the idea of combining several markers into panels to improve clinical performances has emerged. In this article, we present a discussion of the bioinformatics aspects of biomarker panels and the concomitant challenges, including high dimensionality and low patient number and reproducibility.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19929612 DOI: 10.1586/epr.09.83
Source DB: PubMed Journal: Expert Rev Proteomics ISSN: 1478-9450 Impact factor: 3.940